Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Pfizer Ltd reported an 85% net profit jump in Q4 2025, with net earnings reaching Rs 330.94 crore due to exceptional gains ...

3SBio's shares surged 32% to 19.18 Hong Kong dollars, equivalent to US$2.45, on Tuesday after the Chinese company said it would receive an upfront payment of US$1.25 billion and potential milestone ...

UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Beam Therapeutics Inc.’s BEAM share price has surged by 7.36%, which has investors questioning if this is right time to sell.

Sangamo Therapeutics, Inc.’s SGMO share price has surged by 5.70%, which has investors questioning if this is right time to sell.

Medication company Viatris (NASDAQ:VTRS) in Q1 CY2025, with sales falling 11.2% year on year to $3.25 billion. The company’s ...

Pfizer’s positive comments about the impact of a potential tariff being manageable led the stock to increase despite a softer quarterly performance. Nonetheless, a single quarter’s results are ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... This data indicated resiliency in the labor market despite stock market uncertainty in April due to tariff concerns.

But I actually see this as a risk factor since according to my earlier analysis, Pfizer ... company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is ...

Still, Pfizer stock has fallen 10% year to date and hasn’t provided the defensive hedge that many of its Zacks Large Cap Pharmaceutical peers have been able to provide, such as AbbVie ABBV ...